Immunespec provides an advanced immunepeptidomics platform for a faster, more accurate identification of immunogenic peptides using a renewed, mass spectrometry (MS)-based approach. Immunespec enables lifescience companies, biotech companies and CRO's in the development of broad-spectrum vaccines, personalized medicine and immunotherapeutics.
Location: Belgium, Antwerp, Niel
Employees: 1-10
Founded date: 2023
Investors 1
| Date | Name | Website |
| 04.04.2023 | Heran Part... | heranpartn... |
Mentions in press and media 1
| Date | Title | Description |
| 24.03.2023 | HERAN Partners announces EUR 1,2m investment in ImmuneSpec to accelerate their advanced immunopeptidomics platform | You can find the original press release by ImmuneSpec here. |